The Discounted Cash Flow (DCF) valuation of Fredun Pharmaceuticals Ltd (539730.BO) is 1,129.58 INR. With the latest stock price at 1,730.50 INR, the upside of Fredun Pharmaceuticals Ltd based on DCF is -34.7%.
Based on the latest price of 1,730.50 INR and our DCF valuation, Fredun Pharmaceuticals Ltd (539730.BO) is a sell. selling 539730.BO stocks now will result in a potential gain of 34.7%.
| Range | Selected | |
| WACC / Discount Rate | 14.0% - 16.9% | 15.4% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 910.69 - 1,454.44 | 1,129.58 |
| Upside | -47.4% - -16.0% | -34.7% |